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Sequence alterations in RX in patients with microphthalmia,
anophthalmia, and coloboma
Eye development is an intricate process that occurs early
in  embryogenesis  and  is  governed  by  a  highly  organized
sequence of genetic events. Perturbation of these events may
result  in  a  wide  range  of  congenital  eye  malformations.
Microphthalmia, anophthalmia, and coloboma are examples
of such malformations, and are thought to have significant
genetic components [1-6].
Rx is a paired-domain homeobox gene that is essential for
vertebrate eye development. It is strongly expressed in the
retina and anterior neural fold during early embryogenesis. Its
product is a transcription factor that directs initial retinal cell
specification and subsequent proliferation, and is expressed
weakly  in  the  adult  retina,  restricted  to  the  zone  of
proliferating  cells  [7].  Rx  gene  structure  and  protein
homeodomains  are  functionally  conserved  among  species
[7-12], and Rx appears to be essential for proper vertebrate
eye development [9,10,13-16]. Retinal development involves
a complex orchestration of gene activation and expression.
Nrl,  Rx,  and  Pax6  are  3  of  many  important  transcription
factors. These also include CHX10, CRX, ET, Six3, Optx2,
Tlx, and Lhx2. These genes form a genetic network that is
largely conserved from flies to humans. Rx is one of the
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earliest of these to be expressed, and is essential for normal
eye development.
Rx increases the transcription of other eye-specific genes,
including Pax6. However, the direct interactions between Rx
and Pax6 have not been elucidated. Neural retina leucine
zipper  (Nrl)  is  a  basic  leucine  zipper  protein  of  the  Maf
subfamily  that  is  preferentially  expressed  in  rod
photoreceptors. It acts synergistically with the homeodomain
protein  CRX  to  regulate  rhodopsin  transcription.  Direct
interactions have been shown between Nrl and CRX. Targeted
homozygous deletion of the Rx gene in the mouse results in
anophthalmia [7]. Rx mutations have been identified in several
animal  models  of  anophthalmia,  including  mouse  [14],
medaka  (the  Japanese  killfish)  [11],  zebrafish  [17],  and
Xenopus [18,19]. Rx protein homology is well conserved, and
is identical in Xenopus, Drosophila, and zebrafish.
Voronina  et  al.  [2]  identified  and  characterized
compound  heterozygous  RX  mutations  in  a  patient  with
autosomal  recessive  microphthalmia  of  one  eye  and
sclerocornea of the other. The patient had a truncated allele
(Q147X), which affected nuclear localization, and a missense
mutation (R192Q), which affected DNA-binding. Both alleles
were within the homeodomain of the RX protein and were
likely sufficient to account for the patient’s phenotype. The
researchers also reported two polymorphisms (E44/D44 and
Q294Q) in the first and third exons of RX. More recently,
Lequeux and coworkers [20] confirmed the involvement of
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Purpose: Microphthalmia, anophthalmia, and coloboma are ocular malformations with a significant genetic component.
Rx is a homeobox gene expressed early in the developing retina and is important in retinal cell fate specification as well
as stem cell proliferation. We screened a group of 24 patients with microphthalmia, coloboma, and/or anophthalmia for RX
mutations.
Methods: We used standard PCR and automated sequencing techniques to amplify and sequence each of the three RX
exons. Patients’ charts were reviewed for clinical information. The pathologic impact of the identified sequence variant
was analyzed by computational methods using PolyPhen and PMut algorithms.
Results: In addition to the polymorphisms we identified a single patient with coloboma having a heterozygous nucleotide
change (g.197G>C) in the first exon that results in a missense mutation of arginine to threonine at amino acid position 66
(R66T). In silico analysis predicted R66T to be a deleterious mutation.
Conclusions: Sequence variations in RX are uncommon in patients with congenital ocular malformations, but may play
a role in disease pathogenesis. We observed a missense mutation in RX in a patient with a small, typical chorioretinal
coloboma, and postulate that the mutation is responsible for the patient’s phenotype.RX  in  human  anophthalmia  by  reporting  a  patient  with
bilateral  anophthalmia  and  compound  heterozygous
mutations. Our study sought to build upon these findings and
to  further  examine  the  role  of  RX  in  congenital  ocular
malformations.  We  screened  a  group  of  24  patients  with
colobomatous  microphthalmia  for  RX  mutations,  and
correlated our findings with the clinical phenotype of the
patients.
METHODS
Patients: This study was approved by the Internal Review
Board of the Cleveland Clinic Foundation. All blood samples
were obtained after informed consent was secured. A total of
24 index patients were studied: 2 with a positive family history
while  the  remaining  22  had  no  known  immediate  family
history  of  ocular  malformations.  These  are  all  patients
microphthalmia,  anophthalmia,  and  colobomas  who  have
consented to participate in a study of the genetics of eye
diseases  at  the  Cole  Eye  institute.  All  patients  received
diagnoses  through  ophthalmologic  examination.  Patients’
charts were reviewed for clinical information (Appendix 1).
A total of 222 unrelated individuals without symptoms or a
family history of retinal disease were used as normal control
subjects. The controls were recruited from patients and their
families who visit the Cole Eye Institute for routine eye care.
All have signed informed consent to participate in this study.
Mutation detection: Leukocyte nuclei were prepared from
blood samples followed by DNA purification using standard
protocols. Five ml of venous blood was drawn from each
individual. Leukocyte nuclei were purified and DNA was
extracted using Gentra Puregene® Blood Kit before PCR
analysis. PCR products corresponding to the complete known
RX  coding  sequence  (NM_013833)  were  amplified  from
genomic DNA and analyzed by direct sequencing using an
automated sequencer. The primers described in Table 1. PCR
reactions were tailored to each primer pair to yield optimal
amplification.  Cycling  conditions  were  as  follows:
denaturation at 95 °C for 5 min, 40 cycles of 94 °C for 60 s,
59 °C for 30 s, and 74 °C for 45 s, and a final extension at
74 °C for 5 min.
PCR products were gel-purified. They were then directly
sequenced, using the SequiTherm Excel II DNA sequencing
kit (Epicenter Technologies, Madison, WI), on an automated
sequencer (3130XL; Applied Biosystems, Foster City, CA).
Computational assessment of R66T: Two sequence homology
based programs were used to predict the functional impact of
R66T:  PolyPhen  (polymorphism  phenotyping)  and  PMut.
PolyPhen structurally analyzes an amino acid polymorphism
and predicts whether that amino acid change is likely to be
deleterious to protein function [21]. The prediction is based
on  the  position  specific  independent  counts  (PSIC)  score
derived from multiple sequence alignments of observations.
PolyPhen  scores  of  >2.0  indicate  the  polymorphism  is
probably damaging to protein function; scores of 1.5–2.0 are
possibly damaging; and scores of <1.5 are likely benign. PMut
allows the accurate pathological prediction of single amino
acid mutations based on the use of neural networks [22].
Following the input of a reference sequence and the amino
acid substitution of interest, the algorithm provides an answer
and a reliability index. An output value >0.5 is predicted to be
a  pathological  mutation  and  a  value  <0.5  is  neutral.  The
reliability is considered good with a score of 6 and greater and
is highly reliable at the maximum score of 9.
RESULTS
Malformations represented by our patient population included
10 diagnosed with isolated coloboma, 6 with colobomatous
microphthalmia,  5  with  isolated  microphthalmia,  1  with
microphthalmia and anophthalmia, 1 with anophthalmia, and
1 with nanophthalmos (Appendix 1).
We identified 2 polymorphisms (E44/D44 and Q294Q)
that have previously been described by Voronina et al. [2] The
first (E44/D44) involves either glutamic acid or aspartic acid
being found at amino acid 44 of exon 1. The second (Q294Q)
is a silent mutation with either A or G in the third codon
position of amino acid 294 in exon 3. Of the 24 patients, 7
carried  the  E44/D44  polymorphism,  6  the  Q294Q
polymorphism, and 4 patients carried both (Appendix 1). We
compared  the  patient’s  phenotypes  with  the  observed
nucleotide  variations.  Diagnoses  among  the  7  patients
carrying the E44/D44 polymorphism consisted of isolated
coloboma  (3),  microphthalmia  (2),  colobomatous
microphthalmia  (1),  and  combined  anophthalmia–
microphthalmia (1). Diagnoses among the 6 patients carrying
the  Q294Q  polymorphism  consisted  of  coloboma  (5)  and
microphthalmia (1).
In  addition,  we  identified  a  single  patient  with  a
heterozygous nucleotide change, G>C at nucleotide position
197 in the first exon, that results in a missense mutation of
arginine to threonine at amino acid position 66 (R66T; Figure
1). The patient also carried both polymorphisms. The patient’s
ocular phenotype was a small, typical retinal coloboma of the
TABLE 1. LISTING OF PCR PRIMERS USED TO AMPLIFY RX IN THIS STUDY.
Exon Sense primer Antisense primer
1 GGGCGCCCGAACGGCCCTC GCCTCTCCTCTCCGTCTCC
2 GGAGTGCATCTGACCCTCC TGGCTGCAATTTGGGCCTCG
3 GAGCTGAACCGGCTCAGG GGATCCCAAGACGTTCCCC
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163right  eye  (Figure  2).  In  silico  analysis  using
PolyPhenpredicted  R66T  to  be  possibly  damaging  to  the
protein. A large difference (1.602) was noted in PSIC scores
between the allelic variants arginine versus threonine. This
difference indicates that the observed substitution is rarely or
never observed in the RX protein family and is predictive of
a structurally damaging mutation that alters the function of the
protein. PMutanalysis also predicts R66T to be pathological
with high reliability.
We analyzed the DNA of 222 unaffected individuals and
did not find the g.197G>C mutation in these patients. We did
Figure 1. DNA sequence of the RX heterozygous R66T mutation.
DNA sequence of the RX heterozygous mutation R66T in exon 1 in
a coloboma patient and the corresponding DNA sequence in a control
individual. Abbreviations: A.A. is Amino acid, Asp is aspartic acid,
Arg is arginine, Leu is leucine, Gly is glycine.
Figure 2. Fundus photographs of the patient with RX mutation, R66T.
Right fundus with small typical coloboma at the inferior edge of the
nerve that is vertically elongated. Note the pattern of exit of the
inferior arcade vessels, indicating the presence of the coloboma.
observe the polymorphisms reported by Voronina et al. [2]
(E44/D44 and Q294Q) in both patients and controls. We did
not observe either of previously described mutations (Q147X
or R192Q) in any of the patients.
DISCUSSION
It is the complexity of eye development that underlies the
diversity  of  structural  eye  disease,  with  numerous
opportunities for disruption [23]. Environmental factors have
been suggested to play a role in the malformations, including
exposure to infections as well as toxins during pregnancy
[24-28]. More intensely scrutinized, however, are the genetic
contributions. Several genes known to be important in ocular
development  have  been  implicated,  including  PAX6,  RX,
SOX2, OTX2, CHX10, PAX2, SHH, and SIX6. We found a
missense mutation in RX in a patient with a small, typical
retinal coloboma. RX mutations have been associated with
primarily severe ocular malformations such as anophthalmia
[2,20]. Our findings suggest a possible role for RX in later
developmental stages that have not previously been described,
particularly  latter-stage  closure  of  the  optic  fissure.
Unfortunately  family  members  of  our  patient  were  not
examined; therefore we cannot comment on the inheritance
pattern of this mutation. While the 2 previous reports suggest
a recessive mode for severe ocular malformations such as
anophthalmia, we believe that there may be a dosage effect of
this gene. When 2 pathogenic mutations are present [2,20],
anophthalmia or severe microphthalmia is produced. In our
case, this single mutation results in a reduced dosage of the
protein and leads to a minor malformation, a small coloboma
at the optic nerve head.
Several  genetic  mutations  have  been  implicated  in
microphthalmia and anophthalmia. Glaser et al. [1] described
homozygous loss of function mutations in PAX6 in a patient
with  anophthalmia  and  central  nervous  system
malformations.  Mutations  in  SOX2  cause  predominantly
anophthalmia  [6,29,30].  Mutations  in  OTX2  have  been
associated with various severe eye malformations, including
anophthalmia and microphthalmia [31]. PAX2 malformations
have been associated with optic nerve coloboma [4,5,32],
SIX6  mutations  with  bilateral  anophthalmia  and  pituitary
abnormalities [33] as well as microphthalmia [34], CHX10
mutations with microphthalmia [3], and SHH mutations with
human microphthalmia and coloboma [35].
Rx gene structure and protein homeodomains are well
conserved among species [7-12], and animal studies have
established Rx as a high-order gene in ocular development.
Mathers et al. [7] showed in knockout studies in mice that
elimination of Rx prevented eye formation. In a zebrafish
model of anophthalmia (chokh mutation), Loosli et al. [11]
showed that the mutation resulted from a nonsense mutation
in the homeodomain of Rx3, leading to a severely truncated
protein. Tucker et al. [14] established that the mouse eyeless
mutation is secondary to a disrupted translation initiation site
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[18] showed that the Xenopus model of anophthalmia is due
to elimination of Rx function.
In  human  subjects,  sequence  variations  in  RX  are
uncommon  in  patients  with  major  congenital  ocular
malformations, but may play a role in the pathogenesis of
these malformations. Voronina et al. [2] described a patient
with  anophthalmia  OD  and  sclerocornea  OS  who  was  a
compound heterozygote for RX mutations. The patient had a
truncated allele (Q147X), which affected nuclear localization,
and  a  missense  mutation  (R192Q),  which  affected  DNA
binding. Both alleles were within the homeodomain of the RX
protein and were likely sufficient to account for the patient’s
phenotype. Lequeux et al. [20] report a patient with bilateral
anophthalmia and two mutations in exon 3 (c.664delT and c.
909C>G) that lead to premature truncation of the protein,
We describe a heterozygous missense mutation in the first
exon of RX in a patient with a small, typical optic nerve
coloboma of the right eye. We postulate that the mutation is
responsible for the patient’s phenotype. Given the importance
of Rx in eye development, it is possible that even a small
perturbation  would  result  in  an  ocular  defect.  While  the
majority of research delineates the role of Rx in the initial
stages of ocular development, and the majority of functional
studies  have  been  knockout  experiments  that  resulted  in
severe malformations, there is also evidence that Rx plays a
role in the later stages of retinal development. Our finding
strengthens this evidence and implies that Rx plays a role in
closure of the optic fissure in addition to its other established
roles. It is possible that the location of the sequence variation
outside the homeobox or the paired box may explain the mild
nature  of  the  colobomatous  defect.  A  sequence  variation/
mutation within the homeobox or the paired box may have
caused a more severe phenotype.
The g.197G>C nucleotide change results in an alteration
in the primary amino acid sequence from a large, positively-
charged amino acid (arginine) to a small, neutral amino acid
(threonine).While we have yet to characterize the functional
consequences  of  this  change,  it  is  conceivable  that  the
secondary and tertiary structures are sufficiently affected to
alter the function of the protein. To predict the potential effect
of the R66T missense change, we obtained estimates of the
impact  of  this  mutation  through  the  use  of  two  sequence
homology-based  programs.  Both  the  PolyPhenand
PMutalgorithms  predict  this  amino  acid  change  to  be
structurally damaging to the RAX protein. However, it is also
possible that the mutation we discovered in this patient is not
related to the phenotype, but is rather a coincidental finding.
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166Appendix 1. Clinical details of all cases.
Table  summarizing  clinical  details  and  RX  sequence
variations in 24 patients with ocular malformations of the
microphthalmia/coloboma/anophthalmia  spectrum.
Abbreviations: male (M), female (F), autosomal dominant
(AD), right eye, (OD), left eye (OS), both eyes (OU). To
access the data, click or select the words “Appendix 1.” This
will initiate the download of a compressed (pdf) archive that
contains the file.
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